[go: up one dir, main page]

CA2188182A1 - Sequences receptrices de lymphocytes t conservees - Google Patents

Sequences receptrices de lymphocytes t conservees

Info

Publication number
CA2188182A1
CA2188182A1 CA 2188182 CA2188182A CA2188182A1 CA 2188182 A1 CA2188182 A1 CA 2188182A1 CA 2188182 CA2188182 CA 2188182 CA 2188182 A CA2188182 A CA 2188182A CA 2188182 A1 CA2188182 A1 CA 2188182A1
Authority
CA
Canada
Prior art keywords
cells
tcr
cdr3
seq
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2188182
Other languages
English (en)
Inventor
Steven M. Friedman
Mary K. Crow
Yixin Li
Joseph R. Tumang
Guang-Rong Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York Society for Relief of Ruptured and Crippled
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2188182A1 publication Critical patent/CA2188182A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA 2188182 1994-04-18 1995-04-14 Sequences receptrices de lymphocytes t conservees Abandoned CA2188182A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22928594A 1994-04-18 1994-04-18
US229,285 1994-04-18

Publications (1)

Publication Number Publication Date
CA2188182A1 true CA2188182A1 (fr) 1995-10-26

Family

ID=22860556

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2188182 Abandoned CA2188182A1 (fr) 1994-04-18 1995-04-14 Sequences receptrices de lymphocytes t conservees

Country Status (4)

Country Link
EP (1) EP0753060A4 (fr)
JP (1) JPH10504181A (fr)
CA (1) CA2188182A1 (fr)
WO (1) WO1995028481A1 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19625191A1 (de) * 1996-06-24 1998-01-02 Boehringer Mannheim Gmbh Nierenkarzinom-spezifische T-Zellen
US8691510B2 (en) 2008-11-07 2014-04-08 Sequenta, Inc. Sequence analysis of complex amplicons
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
EP2719774B8 (fr) 2008-11-07 2020-04-22 Adaptive Biotechnologies Corporation Procédés de surveillance de maladies par l'analyse de séquence
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
EP2387627B1 (fr) 2009-01-15 2016-03-30 Adaptive Biotechnologies Corporation Profilage d'immunité adaptative et méthodes de génération d'anticorps monoclonaux
RU2014144463A (ru) 2009-06-25 2015-06-20 Фред Хатчинсон Кансэр Рисёч Сентер Способ измерения адаптивного иммунитета
US9043160B1 (en) 2009-11-09 2015-05-26 Sequenta, Inc. Method of determining clonotypes and clonotype profiles
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
AU2012325791B2 (en) 2011-10-21 2018-04-05 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
ES2683037T3 (es) 2011-12-09 2018-09-24 Adaptive Biotechnologies Corporation Diagnóstico de tumores malignos linfoides y detección de enfermedad residual mínima
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
DK2823060T3 (en) 2012-03-05 2018-05-28 Adaptive Biotechnologies Corp Determination of associated immune receptor chains from frequency-matched subunits
WO2013169957A1 (fr) 2012-05-08 2013-11-14 Adaptive Biotechnologies Corporation Compositions et procédé de mesure et de calibrage d'un biais d'amplification dans des réactions de pcr multiplexe
EP3330384B1 (fr) 2012-10-01 2019-09-25 Adaptive Biotechnologies Corporation Évaluation de l'immunocompétence par la diversité adaptative du récepteur immunitaire et la caractérisation de la clonalité
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
AU2015227054A1 (en) 2014-03-05 2016-09-22 Adaptive Biotechnologies Corporation Methods using randomer-containing synthetic molecules
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
EP3132059B1 (fr) 2014-04-17 2020-01-08 Adaptive Biotechnologies Corporation Quantification de génomes de cellules de l'immunité acquise dans un mélange complexe de cellules
US10392663B2 (en) 2014-10-29 2019-08-27 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from a large number of samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
US11066705B2 (en) 2014-11-25 2021-07-20 Adaptive Biotechnologies Corporation Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
WO2016138122A1 (fr) 2015-02-24 2016-09-01 Adaptive Biotechnologies Corp. Méthodes pour le diagnostic d'une maladie infectieuse et la détermination du statut hla à l'aide du séquençage du répertoire immunitaire
US11041202B2 (en) 2015-04-01 2021-06-22 Adaptive Biotechnologies Corporation Method of identifying human compatible T cell receptors specific for an antigenic target
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886743A (en) * 1985-04-24 1989-12-12 California Institute Of Technology Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof
US5298396A (en) * 1989-11-15 1994-03-29 National Jewish Center For Immunology And Respiratory Medicine Method for identifying T cells disease involved in autoimmune disease
DK0529033T3 (da) * 1991-02-08 2007-01-08 Aventis Pharma Sa Nukleotidsekvenser, der koder for variable regioner af a-kæder i humane lumfocytreceptorer samt anvendelser heraf
CA2116526A1 (fr) * 1991-08-28 1993-03-18 William V. Williams Therapie basee sur les recepteurs des cellules t contre l'arthrite rhumatoide
WO1993006135A1 (fr) * 1991-09-23 1993-04-01 Genentech, Inc. Diagnostic et therapie de maladies auto-immunitaires

Also Published As

Publication number Publication date
EP0753060A1 (fr) 1997-01-15
EP0753060A4 (fr) 1999-11-24
JPH10504181A (ja) 1998-04-28
WO1995028481A1 (fr) 1995-10-26

Similar Documents

Publication Publication Date Title
CA2188182A1 (fr) Sequences receptrices de lymphocytes t conservees
AU672313B2 (en) Composition for preventing or treating a T cell mediated pathology
AU635202B2 (en) Anti-t-cell receptor determinants as autoimmune disease treatment
Lin et al. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris.
AU652540B2 (en) T cell receptor peptides as therapeutics for autoimmune and malignant disease
US5614192A (en) T cell receptor peptides as therapeutics for immune-related disease
US5985552A (en) Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
EP0722738A2 (fr) Vaccination et procédés contre des maladies issues de réponses pathogènes par des populations spécifiques de cellules T
JP2009029833A (ja) Ｃｄ２８／ｃｔｌａ−４阻害性ペプチド模倣物、それらの医薬組成物、およびそれらを使用する方法
Li et al. CDR3 sequence motifs shared by oligoclonal rheumatoid arthritis synovial T cells. Evidence for an antigen-driven response.
CA2110055C (fr) Utilisation de peptides du recepteur de lymphocytes t contre les maladies du systeme immunitaire
US6221352B1 (en) Method of preventing the proliferation of Vβ14 or Vβ17-Expressing T cells
EP0463080A1 (fr) Produits pharmaceutiques a base de cd8
Manfredi et al. CD4+ T‐epitope repertoire on the human acetylcholine receptor α subunit in severe myasthenia gravis: A study with synthetic peptides
AU3418893A (en) Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
US6303750B1 (en) Conserved T-cell receptor sequences
AU669329B2 (en) Method of modulating mammalian T-cell response
US6159470A (en) Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
Struijk et al. Inflamed joints of patients with rheumatoid arthritis contain T cells that display in vitro proliferation to antigens present in autologous synovial fluid functional analysis on the basis of synovial-fluid-reactive T-cell clones and lines
WO1999027957A1 (fr) Vaccination et procede de lutte contre la sclerose en plaques au moyen de peptides tcr vbeta specifiques
AU4920093A (en) Reagents and methods for treating rheumatoid arthritis
JPH11514968A (ja) 筋無力症の処置のためのヌクレオチドおよびペプチド配列

Legal Events

Date Code Title Description
FZDE Dead